155 results
Page 3 of 8
S-4/A
66xfjpn 0sjbj
25 Sep 19
Registration of securities issued in business combination transactions (amended)
9:44pm
S-4
ovb9l22
29 Aug 19
Registration of securities issued in business combination transactions
9:48pm
425
sofkq
12 Aug 19
Business combination disclosure
5:06pm
8-K
EX-2.1
v0t0pdl5tpu hvkirp
30 Jul 19
Entry into a Material Definitive Agreement
5:07pm
425
EX-2.1
fo52eznent
30 Jul 19
Business combination disclosure
5:06pm
425
tno96
30 Jul 19
Business combination disclosure
12:00am
8-K
EX-99
8yj9g2
29 Jul 19
Second-quarter revenue increased 94 percent to $200 million and Cologuard test volume increased 93 percent to 415,000
7:21am
425
EX-99
cmvwoimr c9v61
29 Jul 19
Business combination disclosure
7:20am
8-K
EX-99.1
ompnyah r3
29 Jul 19
Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company
7:18am
425
EX-99.1
pa9ah
29 Jul 19
Business combination disclosure
7:16am
8-K
EX-99.1
43vt81xyrr 0z
30 Apr 19
First-quarter revenue and Cologuard test volume increased 79 percent to $162 million and 334,000, respectively
4:14pm
8-K
EX-1.1
tn06 0ltqfyk
8 Mar 19
Exact Sciences Announces Offering of $600 Million Convertible Senior Notes Due 2027
4:30pm
8-K
EX-99.1
aa93kinl
7 Jan 19
Results of Operations and Financial Condition
8:42am
DEFR14A
vn3v14 nn
15 Jun 18
Revised proxy
4:14pm